the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI

Launched by HANGZHOU MEDICAL COLLEGE · Mar 10, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating the effects of a special treatment called TCM Sniffing Therapy combined with Electroacupuncture for patients who have experienced cognitive impairment after a stroke. The trial aims to see if this combined therapy can help improve thinking and memory in stroke survivors. Participants will be divided into different groups to receive either the combination therapy, just one of the therapies, or a placebo treatment that does not have any active medicine.

To be eligible for this study, participants must be under 70 years old and have experienced a stroke related to specific symptoms, such as weakness on one side of the body or difficulty speaking. They should also show signs of cognitive difficulties, as measured by a simple memory test, and be within six months of their stroke. Participants will be closely monitored during the trial, and those who agree to take part will need to provide consent. This study is currently recruiting, so it's an excellent opportunity for eligible individuals to potentially benefit from new treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • (1) Stroke as per the TCM definition, presenting symptoms include unilateral paresis or paralysis, sensory deficits, speech impairment, and hemianopsia. PSCI diagnosis involves clinically significant deficits in at least one cognitive domain and severe disruption of instrumental ADLs/ADLs.; (2) The scores on the MMSE scale must adhere to the following criteria: Less than 17 points for individuals with illiteracy, less than 20 points for those with primary school education, and less than 24 points for individuals with a middle school education or higher.; (3) Aged under 70 years; (4) No history of mental illness, clear consciousness, stable vital signs, and able to complete the scale assessment; (5) Within 6 months post-stroke, diagnosed as a patient in the recovery period of cerebral infarction (or cerebral hemorrhage) at admission; (6) Signed informed consent by the patient or their family.
• Exclusion Criteria:
• • (1) Transient ischemic attack; (2) Subarachnoid hemorrhage; (3) History of severe liver or kidney diseases, mental illness, epilepsy, asthma, or obstructive pulmonary diseases; (4) Occurrence of cognitive impairment prior to stroke; (5) Severe communication barriers; (6) Substance abuse or heavy alcohol consumption; (7) Implanted cardiac pacemakers or other electronic devices.